此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Artificial Intelligence for Diagnosing Periodontitis and Monitoring Gingival Inflammation

Evaluation of Artificial Intelligence Models for Periodontitis Diagnosis and Gingival Inflammation Monitoring at Tooth and Patient Levels: A Diagnostic Accuracy Study

Background and Objective:

Periodontitis and gingivitis are highly prevalent oral diseases that require accurate diagnostic classification and continuous gingival health monitoring. This study aims to develop, internally validate, and externally evaluate the diagnostic accuracy of artificial intelligence (AI) models for periodontitis staging and gingival inflammation assessment at both tooth and patient levels.

Study Design:

This is a multi-center observational study utilizing a large-scale primary clinical dataset for model development. To rigorously evaluate the generalizability of the trained AI models, two distinct pathways of independent external validation will be implemented across multiple clinical sites.

Research Phases & Validation Architecture:

Phase 1 (Periodontitis Diagnosis via Probing): Development of an AI model to diagnose periodontitis (binary classification: stage 0/I vs. stage II/III/IV) at both tooth and patient levels, using comprehensive clinical periodontal probing as the gold standard. External Validation I will be performed using an independent cohort from another campus of the primary hospital to test the model's diagnostic accuracy.

Phase 2 (Periodontitis Diagnosis via Radiographs): Development of an AI model to diagnose periodontitis (binary classification: stage 0/I vs. stage II/III/IV) at both tooth and patient levels, using digital panoramic radiographs as the reference standard. External Validation II will be conducted using distinct, independent image datasets acquired from two separate regional hospitals to evaluate geographic generalizability.

Phase 3 (Gingival Inflammation Monitoring): Development of an AI model to monitor and assess gingival inflammation at both tooth and patient levels, based on Probing Depth (PD) and Bleeding on Probing (BOP) as the gold standard. This model's performance will also be evaluated through External Validation I using the independent dataset from the primary hospital's alternative campus.

Significance:

By validating the AI models across varied institutional workflows and imaging systems, this study will provide high-level evidence on the clinical utility and robustness of AI-driven digital systems for automated periodontal screening and long-term health monitoring.

研究概览

研究类型

观察性的

注册 (估计的)

900

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Shanghai、中国
        • Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

取样方法

非概率样本

研究人群

The study population consists of adult patients who sought routine dental care or periodontal evaluation at the primary medical center (including its main campus and an alternative secondary campus) and two independent regional hospitals. This multi-center population reflects a real-world, diverse clinical screening pool of patients presenting with varying degrees of periodontal health, ranging from completely healthy gingiva to severe, advanced periodontitis. Eligible participants are identified based on the availability of concurrent full-mouth clinical periodontal charting and digital panoramic radiographs.

描述

Inclusion Criteria:

  1. Patients aged > 18 years at the time of their clinical periodontal examination.
  2. Availability of complete full-mouth periodontal charting records, which must include Probing Depth (PD) and Bleeding on Probing (BOP) documented at 6 sites per tooth.
  3. Availability of a digital panoramic radiograph of acceptable diagnostic quality, taken within one months of the clinical periodontal examination.

Exclusion Criteria:

  1. Patients who are completely edentulous or those who have undergone full-arch dental implant rehabilitation (not applicable for natural teeth periodontitis staging).
  2. Panoramic radiographs with severe image degradation, including major motion artifacts, severe positioning errors, or poor contrast/exposure that obscures the alveolar bone crest.
  3. Presence of extensive metal artifacts or massive bilateral multiple fixed crowns/bridges that completely shadow the marginal bone level of interest.
  4. Incomplete clinical electronic medical records or missing core diagnostic descriptors required to establish the clinical gold standard for periodontitis staging or gingival inflammation.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Multi-center Periodontal AI Development and Validation Cohort

Development Dataset (Primary Campus): Large-scale data used for the initial training and internal validation of the AI algorithms.

External Validation Dataset I (Secondary Campus): An independent dataset from an alternative campus of the primary hospital, used to validate clinical probing-based periodontitis diagnosis (Phase 1) and gingival inflammation monitoring (Phase 3).

External Validation Dataset II (Two Regional Hospitals): Separate imaging datasets from two distinct regional medical centers, used to validate radiograph-based periodontitis diagnosis (Phase 2).

The intervention evaluated in this observational study is the deployment of deep learning/artificial intelligence (AI) software models.

The AI algorithms process two streams of standard clinical data to perform three automated diagnostic tasks without altering patient care:

Automated classification of periodontitis stages (Stage 0/I vs. Stage II/III/IV) utilizing full-mouth clinical charting metrics.

Automated classification of periodontitis stages (Stage 0/I vs. Stage II/III/IV) utilizing digital panoramic radiographs.

Automated assessment and monitoring of gingival inflammation flags based on Probing Depth (PD) and Bleeding on Probing (BOP) patterns.

The outputs of these AI models will be directly compared against clinical and radiographic gold standards to calculate diagnostic accuracy metrics.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Diagnostic Accuracy of the AI Model for Probing-Based Periodontitis Staging
大体时间:Baseline (At a single point in time for each participant (cross-sectional assessment))
The diagnostic performance of the deep learning AI model in classifying periodontitis stages (binary classification: Stage 0/I vs. Stage II/III/IV) at both individual tooth and patient levels, using comprehensive clinical periodontal probing as the gold standard. Performance will be evaluated using the internal development dataset and verified using External Validation Dataset I (secondary campus data). Metrics will include Area Under the Receiver Operating Characteristic curve (AUC), Sensitivity, Specificity, and F1-score.
Baseline (At a single point in time for each participant (cross-sectional assessment))
Diagnostic Accuracy of the AI Model for Radiograph-Based Periodontitis Staging
大体时间:Baseline (At a single point in time for each participant (cross-sectional assessment))
The diagnostic performance of the deep learning AI model in classifying periodontitis stages (binary classification: Stage 0/I vs. Stage II/III/IV) at both individual tooth and patient levels, using digital panoramic radiographs as the reference standard. Performance will be evaluated using the internal development dataset and verified using External Validation Dataset II (multi-center data from two separate regional hospitals). Metrics will include Area Under the Receiver Operating Characteristic curve (AUC), Sensitivity, Specificity, and F1-score.
Baseline (At a single point in time for each participant (cross-sectional assessment))
Diagnostic Accuracy of the AI Model for Gingival Inflammation Monitoring
大体时间:Baseline (At a single point in time for each participant (cross-sectional assessment))
The performance of the deep learning AI model in detecting and monitoring gingival inflammation flags at both individual tooth and patient levels, using Probing Depth (PD) and Bleeding on Probing (BOP) metrics as the clinical gold standard. Performance will be evaluated using the internal development dataset and verified using External Validation Dataset I (secondary campus data). Metrics will include Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV).
Baseline (At a single point in time for each participant (cross-sectional assessment))

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年9月10日

初级完成 (实际的)

2026年3月10日

研究完成 (估计的)

2026年9月10日

研究注册日期

首次提交

2026年6月1日

首先提交符合 QC 标准的

2026年6月4日

首次发布 (实际的)

2026年6月5日

研究记录更新

最后更新发布 (实际的)

2026年6月5日

上次提交的符合 QC 标准的更新

2026年6月4日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • SH9H-2025-T196-4

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅